New substituted benzimidazole derivatives: a patent review (2010 – 2012)

Bibliography

• Bonnett R. The chemistry of the vitamin B12 group. Chem Rev 1963;63:573-605
   Web of Science ®Google Scholar
• Radziszewski B. Ueber die constitution des lophins und verwandter verbindungen. Chem Ber 1882;15:1493-6
   Google Scholar
• Townsend LB. Imidazole nucleosides and nucleotides. Chem Rev 1967;67:533-63
   PubMed Web of Science ®Google Scholar
• Feldman D. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr Rev 1986;7:409-20
   PubMed Web of Science ®Google Scholar
• Lee JC, Badger AM, Griswold DE, et al. Bicyclic imidazoles as a novel class of tyrosine biosynthesis inhibitors. Immunosuppressive Antiinflammatory Drugs 1993;696:149-70
   Google Scholar
• Fabio B, Chiara C, Silvia C, Renzo R. Efficient and highly regioselective direct C-2 arylation of azoles, including free (NH)-imidazole, -benzimidazole and -indole, with aryl halides. Tetrahedron 2007;63:1970-80
   Google Scholar
• Katritzky AR, Lan XF, Yang JZ, Denisko OV. Properties and synthetic utility of N-substituted benzotriazoles. Chem Rev 1998;98:409-548
   PubMed Web of Science ®Google Scholar
• Hunger A, Kebrle J, Rossi A, Hoffmann K. Synthesis of analgesically active benzimidazole derivatives with basic substitutions. Experientia 1957;13:400-1
   PubMedGoogle Scholar
• Takahashi S, Kano H. Benzimidazole N-oxides. I. The structure of benzimidazole N-oxide and synthesis of its derivatives. Chem Pharm Bull 1963;11:1375-81
   PubMedGoogle Scholar
• Kadin SB, Eggers HJ, Tamm I. Synthesis and virus-inhibitory activity of D- and L-isomers of 2-(alpha-hydroxy-benzyl)-benzimidazole. Nature 1964;201:639-40
   PubMedGoogle Scholar
• Stanovnik B, Tisler M. Preparation of some benzimidazole- and benzthiazole-2-sulfonamides. Arch Pharm Ber Dtsch Pharm Ges 1965;298:357-63
   PubMedGoogle Scholar
• Holmquist L, Larsson L. Synthesis of 1-(2-diethylaminoethyl)-2-(-hydroxybenzyl)- and 1-(2-diethylaminoethyl)-2-(-acetoxybenzyl)benzimidazoles. Acta Pharm Suec 1972;9:602-4
   PubMedGoogle Scholar
• Pellicciari R, Curini M, Spagnoli N. Preparation of 1-(aroylalkyl)-1H-imidazole and 1-(aroylalkyl)-1H-benzimidazole derivatives of pharmaceutical interest-a new synthetic procedure. Arch Pharm (Weinheim) 1984;317:38-41
   Web of Science ®Google Scholar
• Perry RJ, Wilson BD. A novel palladium-catalyzed synthesis of 2-arylbenzimidazoles. J Org Chem 1993;58:7016-21
   Web of Science ®Google Scholar
• Huang WL, Searborough RM. A new "traceless" solid-phase synthesis strategy: synthesis of a benzimidazole library. Tetrahedron Lett 1999;40:2665-8
   Web of Science ®Google Scholar
• Nadaf RN, Siddiqui SA, Daniel T, et al. Room temperature ionic liquid promoted regioselective synthesis of 2-aryl benzimidazoles, benzoxazoles and benzthiazoles under ambient conditions. J Mol Catalysis A Chem 2004;214:155-60
   Web of Science ®Google Scholar
• Li LH, Wallace TL, DeKoning TF, et al. Structure and activity relationship of several novel CC-1065 analogs. Invest New Drugs 1987;5:329-37
   PubMedGoogle Scholar
• Boger DL, Johnson DS. CC-1065 and the duocarmycins: understanding their biological function through mechanistic studies. Angew Chem Int Ed Engl 1996;35:1438-74
   Web of Science ®Google Scholar
• Copp BR, Ireland CM, Barrows LR. Wakayin-a novel cytotoxic pyrroloiminoquinone alkaloid from the ascidian Clavelina species. J Org Chem 1991;56:4596-7
   Web of Science ®Google Scholar
• Arjmand F, Mohani B, Ahmad S. Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new benzimidazole derived Cu(II) complex. Eur J Med Chem 2005;40:1103-10
   PubMed Web of Science ®Google Scholar
• Díaz-Chiguer DL, Márquez-Navarro A, Nogueda-Torres B, et al. In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi. Acta Trop 2012;122:108-12
   PubMedGoogle Scholar
• Cheng J, Xie J, Luo X. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. Bioorg Med Chem Lett 2005;15:267-9
   PubMed Web of Science ®Google Scholar
• Xue F, Luo XJ, Ye CH, et al. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses. Bioorg Med Chem 2011;19:2641-9
   PubMedGoogle Scholar
• Mao J, Wang Y, Wan B, et al. Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents. ChemMedChem 2007;2:1624-30
   PubMedGoogle Scholar
• Mao J, Wan B, Wang Y, et al. HTS, chemical hybridization, and drug design identify a chemically unique antituberculosis agent-coupling serendipity and rational approaches to drug discovery. ChemMedChem 2007;2:811-13
   PubMedGoogle Scholar
• Lilienkampf A, Mao J, Wan B, et al. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating mycobacterium tuberculosis. J Med Chem 2009;52:2109-18
   PubMed Web of Science ®Google Scholar
• Pieroni M, Lilienkampf A, Wan B, et al. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes. J Med Chem 2009;52:6287-96
   PubMedGoogle Scholar
• Lilienkampf A, Pieroni M, Wan B, et al. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of mycobacterium tuberculosis. A potent and selective series for further drug development. J Med Chem 2010;53:678-88
   PubMedGoogle Scholar
• Pieroni M, Tipparaju SK, Lun SC, et al. Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB. ChemMedChem 2011;6:334-42
   PubMedGoogle Scholar
• Garudachari B, Satyanarayana MN, Thippeswamy B, et al. Synthesis, characterization and antimicrobial studies of some new quinoline incorporated benzimidazole derivatives. Eur J Med Chem 2012;54:900-6
   PubMed Web of Science ®Google Scholar
• Ziółkowska NE, Michejda CJ, Bujacz GD. Structure of HIV-1 nonnucleoside reverse transcriptase inhibitors derivatives of N-benzyl-benzimidazole with different substituents in position 4. J Mol Struct 2010;963:188-93
   Web of Science ®Google Scholar
• Neochoritis CG, Zarganes-Tzitzikas T, Tsoleridis CA, et al. One-pot microwave assisted synthesis under green chemistry conditions, antioxidant screening, and cytotoxicity assessments of benzimidazole Schiff bases and pyrimido[1,2-a]benzimidazol-3(4H)-ones. Eur J Med Chem 2011;46:297-306
   PubMed Web of Science ®Google Scholar
• Achar KCS, Hosamani KM, Seetharamareddy HR. In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur J Med Chem 2010;45:2048-54
   PubMed Web of Science ®Google Scholar
• Li YQ, Tan CY, Gao CM, et al. Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors. Bioorg Med Chem 2011;19:4529-35
   PubMed Web of Science ®Google Scholar
• Jain P, Flaherty PT, Yi SY, et al. Design, synthesis, and testing of an 6-o-linked series of benzimidazoles based inhibitors of CDK5/p25. Bioorg Med Chem 2011;19:359-73
   PubMedGoogle Scholar
• Tuccinardi T, Calderone V, Rapposelli S, Martinelli A. Proposal of a new binding orientation for non-peptide AT1 antagonists: homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis. J Med Chem 2006;49:4305-16
   PubMed Web of Science ®Google Scholar
• Wang JL, Zhang J, Zhou ZM, et al. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists. Eur J Med Chem 2012;49:183-90
   PubMedGoogle Scholar
• Zhang J, Wang JL, Zhou ZM, et al. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1 receptor antagonists. Bioorg Med Chem 2012;20:4208-16
   PubMedGoogle Scholar
• Romero DL, Morge RA, Biles C, et al. Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of nonnucleoside HIV-1 reverse transcriptase inhibitors. J Med Chem 1994;37:999-1014
   PubMed Web of Science ®Google Scholar
• Jablonowski JA, Grice CA, Chai WY, et al. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 2003;46:3957-60
   PubMed Web of Science ®Google Scholar
• Lee-Dutra A, Arienti KL, Buzard DJ, et al. Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands. Bioorg Med Chem Lett 2006;16:6043-8
   PubMed Web of Science ®Google Scholar
• Savall BM, Edwards JP, Venable JD, et al. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands. Bioorg Med Chem Lett 2010;20:3367-71
   PubMedGoogle Scholar
• Beinke S, Ley SC. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem J 2004;382:393-409
   PubMed Web of Science ®Google Scholar
• Romo-Mancillas A, Tellez-Valencia A, Yepez-Mulia L, et al. The design and inhibitory profile of new benzimidazole derivatives against triosephosphate isomerase from Trypanosoma cruzi: a problem of residue motility. J Mol Graph Model 2011;30:90-9
   PubMedGoogle Scholar
• Luo XJ, Xue F, Zhang ZL, Xiu NY. Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses. US20110269766; 2011
   Google Scholar
• Mc Gowan D, Demin SD, Last SJ, et al. Bis-benzimidazole derivatives as hepatitis C virus inhibitors. WO2011015658; 2011
   Google Scholar
• McGowan D, Demin SD, Last SJ, et al. Bis-benzimidazole derivatives as hepatitis C virus inhibitors. US20120135953; 2012
   Google Scholar
• Averin KM, Solodunov YY, Stradomskiy BV. 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity. EP2230233; 2010
   Google Scholar
• Blade H, Carron EA, Jackson HM, et al. Benzimidazole derivatives and their use as antiviral agents. WO2010103306; 2010
   Google Scholar
• Pfau R, Arndt K, Doods H, et al. 1H-benzimidazole-5-carboxamides as anti-inflammatory agents. WO2010034796; 2010
   Google Scholar
• Luo XJ, Xue F, Zhang ZL, Xiu NY. Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses. WO2010078830; 2010
   Google Scholar
• Lappas M, Rice GE. The role and regulation of the nuclear factor kappa B signalling pathway in human labour. Placenta 2007;28:543-56
   PubMedGoogle Scholar
• Winfield LL. Synthesis and anti-proliferative effect of benzimidazole derivatives. US8106084; 2012
   Google Scholar
• Boehringer Ingelheim International GMBH. Benzimidazoles. WO2010012745; 2010
   Google Scholar
• Chen P, Shi L, Liu QX, Hu AX. Methods for preparation of 2,2'-(1,4-phenylene)bis(1H-benzo[d]imidazole-5-carboxylic acid). CN102002001; 2011
   Google Scholar
• Li XL, Lin YJ. The synthesis of benzimidazole incorporated benzo[d]isoquinoline-1,3(2H)-dione derivatives and their anti-tumor activities. CN102206203; 2011
   Google Scholar
• Kamal A, Kumar PP, Seshadri BN, Sreekanth K. Novel benzimidazole linked pyrrolo[2,1-C[1,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof. US20110190268; 2011
   Google Scholar
• Chang CS, Guh JH, Teng CM, et al. Benzimidazole compounds and their use as anticancer agents. US20100179147; 2010
   Google Scholar
• Ortho-McNeil-Janssen Pharmaceuticals Inc. Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators. WO2010094647; 2010
   Google Scholar
• Zhou ZM, Wang JL, Zhang J, et al. A method for preparing 4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxamide derivatives. ZL2010101273205; 2010
   Google Scholar
• Zhou ZM, Zhang J, Li ZH, Wang JL. Method for preparing 6-substituted aminocarbonyl benzimidazole derivatives. PCTCN2011071846; 2010
   Google Scholar
• Zhou ZM, Xue WZ, Zhang J, He X. Preparation methods and uses of 1-tetrazolbiphenyl-6- substituted aminocarbonyl benzimidazole derivatives. ZL2009102379134; 2012
   Google Scholar
• Zhou ZM, Xue WZ, Zhang J, He X. Preparation methods and uses of 1-(3,4-dimethylisoxazole)biphenyl-6- substituted aminocarbonyl benzimidazole derivatives. ZL200910237912X; 2012
   Google Scholar
• Zhou ZM, Wang JL, Xu D, Hao LP. Preparation methods and uses of 6-(N-acyl)aminobenzimidazole derivatives. CN102276534; 2011
   Google Scholar
• Zhou ZM, Xu D, He X, et al. Preparation methods and uses of chiral 1-tetrazolbiphenyl-6-substituted aminocarbonyl benzimidazole derivatives. CN102491971; 2012
   Google Scholar
• Yang H, Zhang X, Zhang T. Method for preparing Telmisartan intermediate. CN102295604; 2011
   Google Scholar
• McKinnell RM, Gendron R, Jiang L, et al. Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists. US20100249186; 2010
   Google Scholar
• Dalziel SM, Phizackerley KM. Crystalline form of a benzimidazole-carboxamide medicinal compound. US20110201644; 2010
   Google Scholar
• Dalziel SM, Phizackerley KM. Crystalline form of a benzimidazole-carboxamide medicinal compound. US20110201644; 2011
   Google Scholar
• Haydar SN, Andrae PM, Yun HD. 2-methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazole as 5-hydroxytryptamine-6-ligand. EP2285784; 2012
   Google Scholar
• Haydar SN, Andrae PM, Yun HD, Robichaud AJ. 1-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazoles as δ-hydroxytryptamine-6 ligands. WO2010056644; 2010
   Google Scholar
• Player MR, Dax SL, Parsons WH, et al. Benzimidazole modulators of VR1. US20110190344; 2011
   Google Scholar
• Kim JD, Yoon HC, Cho SH, et al. Novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and use thereof. US20110086849; 2011
   Google Scholar
• Benson GM, Bleicher K, Feng S, et al. New benzimidazole derivatives and their use as FXR agonists. WO2011039130; 2011
   Google Scholar
• Benson GM, Bleicher K, Feng S, et al. New benzimidazole derivatives and their use as FXR agonists. WO2011039130; 2011
   Google Scholar
• Conn PJ, Lindsley CW, Hopkins CR, et al. Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mGluR4 potentiators. WO2011011722; 2011
   Google Scholar
• Bennani YL, Tumey LN, Gleason EA, Robarge MJ. Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof. US20110105573; 2010
   Google Scholar
• Nakano M, Minoguchi M, Hanano T, et al. Benzimidazole compound and pharmaceutical use thereof. US20100120841; 2010
   Google Scholar
• Calvo RR, Meegalla SK, Player MR. Benzimidazole derivatives useful as TRP M8 receptor modulators. WO2010132247; 2010
   Google Scholar
• Gijsen HJM, Cleyn MAJ, Surkyn M. Benzimidazole cannabinoid agonists. US20100041702; 2010
   Google Scholar
• Ng R, Sui ZH, Guan JH, et al. Novel benzimidazole derivatives useful as selective androgen receptor modulators(SARMs). US20100298383; 2010
   Google Scholar
• Garst ME, Sachs G, Shin JM. Prodrugs of proton pump inhibitors including the (1H-pyrrol-1-yl)-1H-benzimidazole moiety. US20100113524; 2010
   Google Scholar
• Feurer A, Soeberdt M. Substituted benzimidazole derivatives as melanocortin 4 receptor antagonists. EP2439197; 2012
   Google Scholar
• Dillon MP, Krauss NE. Indole, indazole and benzimidazole arylamides as P2X3 and P2X2/3 antagonists. US20100324070; 2010
   Google Scholar
• Larsen JS, Teuber L, Ahring PK, et al. Benzimidazole derivatives and their use for modulating the GABAA receptor comples. US20110118259; 2011
   Google Scholar
• Chen ZD, Hao MH, Liu WM, et al. Benzimidazole inhibitors of leukotriene production. US20110301161; 2011
   Google Scholar
• Kilburn JP, Andersen HS, Kampen GCT. Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors. US20100076041; 2010
   Google Scholar
• Huang A. Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators. WO2012044537; 2012
   Google Scholar
• Zhu GD, Gong JC, Gandhi VB, et al. 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors. AU2012200398; 2012
   Google Scholar
• Berdini V, O'Brien MA, Carr MG, et al. Benzimidazole derivatives and their use as protein kinase inhibitors. US20110224203; 2011
   Google Scholar
• Georges G, Hoffmann E, Kaluza K, et al. Benzimidazole amido derivatives, their manufacture and use as pharmaceutical agents. US20100168181; 2010
   Google Scholar
• Bode CM, Cheng AC, Choquette D. Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase. WO2012018668; 2012
   Google Scholar
• Boezio A, Cheng AC, Coats JR, et al. Indole/benzimidazole compounds as mTOR kinase inhibitors. WO2010096314; 2010
   Google Scholar
• Qu JY, Rivero R, Sanchez R, Tedesco R. Benzimidazole derivatives as PI3 kinase inhibitors. US20120088767; 2012
   Google Scholar
• Rewcastle GW, Giddens AC, Gamage SA. 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy. WO2012044641; 2012
   Google Scholar
• Das S, Thomas A, Khairatkar-Joshi N. Substituted benzimidazole compounds as COT kinase inhibitors. WO2012131501; 2012
   Google Scholar
• Binch H, Mortimore M, Robinson D, et al. 1-pyrimidinyl- or 1-pyridinyl-2-amino benzimidazole derivatives and related compounds as inhibitors of protein kinases for the treatment of cancer. EP2336122; 2011
   Google Scholar
• Chen ZD, Hao MH, Liu WM, et al. Benzimidazole inhibitors of leukotriene production. WO2011068821; 2011
   Google Scholar
• Bookser BC, Dang Q, Gibson TS, et al. Novel cyclic benzimidazole derivatives useful as anti-diabetic agents. US20100081643; 2010
   Google Scholar
• Kwak YS, Coppola GM. Organic compounds. US7879850; 2011
   Google Scholar
• Baraona RM, Rojo L, Azocar RK. Benzimidazole-derived compounds use as markers in the case of neurodegenerative diseases. US20110300072; 2011
   Google Scholar
• Afofarm CJSC. Polymorphic forms of 5-ethoxy-2-[2-(morpholino)-ethylthio]benzimidazole dihydrochloride and processes for their preparation. EP2423200; 2012
   Google Scholar
• Seredenin SB, Blednov YA, Saveliev VL, et al. Pharmacologically active 2-mercaptobenzimidazole derivatives. EP0788795; 1997
   Google Scholar
• De' Felice G. New vaccine adjuvants. WO2010041097; 2010
   Google Scholar
• Ohnishi SK. Method for preparing a veterinary suspension formulation for administering water-insoluble medicaments. WO2010045700; 2010
   Google Scholar
• Bookser BC, Dang Q, Gibson TS, et al. Novel cyclic benzimidazole derivatives useful anti-diabetic agents. WO2010047982; 2010
   Google Scholar
• Jiang JL, Kassick AJ, Kekec A, Sebhat IK. Novel cyclic benzimidazole derivatives useful anti-diabetic agents. WO2011106273; 2011
   Google Scholar
• Eckardt K, Kaltenhäuser J, Kilb C, et al. Relative potency of albendazole and its sulfoxide metabolite in two in vitro tests for developmental toxicity: the rat whole embryo culture and the mouse embryonic stem cell test. Reprod Toxicol 2012;34:378-84
   PubMedGoogle Scholar
• Gokeulut C, Nolan AM, McKellar QA. Plasma disposition, faecal excretion and in vitro metabolism of oxibendazole following oral administration in horses. Res Vet Sci 2002;72:11-15
   PubMedGoogle Scholar
• Dunn GL, Gallagher G, Davis LD, Hoover JRE. Metabolites of methyl 5(6)-butyl-2-benzimidazolecarbamate (Parbendazole). Structure and synthesis. J Med Chem 1973;16:996-1002
   PubMed Web of Science ®Google Scholar
• Carlert S, Akesson P, Jerndal G, et al. In vivo dog intestinal precipitation of Mebendazole: a basic BCS class II drug. Mol Pharm 2012;9:2903-11
   PubMedGoogle Scholar
• Garcia-Mazcorro JF, Suchodolski JS, Jones KR, et al. Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs. FEMS Microbiol Ecol 2012;80:624-36
   PubMed Web of Science ®Google Scholar
• Yin OQP, Gallagher N, Fischer D, et al. Effect of the proton pump inhibitor Esomeprazole on the oral absorption and pharmacokinetics of Nilotinib. J Clin Pharmacol 2010;50:960-7
   PubMed Web of Science ®Google Scholar
• Sugano K, Kontani T, Katsuo S, et al. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol 2012;47:540-52
   PubMed Web of Science ®Google Scholar
• Wu HY, Jing QM, Wang JH, Guo XH. Pantoprazole for the prevention of gastrointestinal bleeding in high-risk patients with acute coronary syndromes. J Crit Care 2011;26:434. e1-434.e6
   PubMed Web of Science ®Google Scholar
• Chong CR, Chen XC, Shi LR, et al. A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol 2006;2:415-16
   PubMed Web of Science ®Google Scholar
• Vorperian VR, Zhou ZF, Mohammad S, et al. Torsade de pointes with an antihistamine metabolite: potassium channel blockade with Desmethylastemizole. JACC 1996;28:1556-61
   Google Scholar
• Barrett IC, Kerr MA. The high-pressure SNAr reaction of N-p-fluorobenzyl-2-chlorobenzimidazole with amines; an approach to Norastemizole and analogues. Tetrahedron Lett 1999;40:2439-42
   Web of Science ®Google Scholar
• Saito T, Hagihara A, Igarashi N, et al. Inhibitory effects of emedastine difumarate on histamine release. Jpn J Pharmacol 1993;62:137-43
   PubMedGoogle Scholar
• Taglialatela M, Pannaccione A, Castaldo P, et al. Inhibition of HERG1 K+ channels by the novel second-generation antihistamine mizolastine. Br J Pharmacol 2000;131:1081-8
   PubMed Web of Science ®Google Scholar
• Wang P, Zheng GJ, Wang YP, et al. Highly practical and cost-efficient synthesis of telmisartan: an antihypertensive drug. Tetrahedron 2012;68:2509-12
   Google Scholar
• Sánchez-Lemus E, Honda M, Saavedra JM. Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress. Behav Brain Res 2012;232:84-92
   PubMedGoogle Scholar
• Zaiken K, Cheng JWM. Azilsartan medoxomil: a new angiotensin receptor blocker. Clin Ther 2011;33:1577-89
   PubMed Web of Science ®Google Scholar
• Ent MVD, Remme WJ, Bartels GL, et al. Contrasting preload-dependent hemodynamic and neurohumoral effects of Isomazole, a partial phosphodiesterase inhibitor and calcium sensitizer. J Card Fail 1997;3:277-86
   PubMedGoogle Scholar
• Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 2012;125:S3-S13
   PubMed Web of Science ®Google Scholar
• Colman PM. New antivirals and drug resistance. Annu Rev Biochem 2009;78:95-118
   PubMedGoogle Scholar
• Kuiken C. Designing a low-cost drug resistance database for viral hepatitis. Antivir Ther 2010;15:517-20
   PubMedGoogle Scholar
• Parija SC, Praharaj I. Drug resistance in malaria. Indian J Med Microbiol 2011;29:243-8
   PubMedGoogle Scholar
• Indran IR, Tufo G, Pervaiz S, Brenner C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta 2011;1807:735-45
   PubMed Web of Science ®Google Scholar
• Kuritzkes DR. Drug resistance in HIV-1. Curr opin Virol 2011;1:582-9
   Google Scholar
• Nishio S, Somete T, Sugie A, et al. Axially chiral macrocyclic E-alkene bearing bisazole component formed by sequential C-H homocoupling and ring-closing metathesis. Org Lett 2012;14:2476-9
   PubMedGoogle Scholar
• Chu LL, Qing FL. Copper-catalyzed direct C-H oxidative trifluoromethylation of heteroarenes. J Am Chem Soc 2012;134:1298-304
   PubMedGoogle Scholar
• Mitsuda S, Fujiwara T, Kimigafukuro K, et al. Copper-catalyzed oxidative C-H, N-H coupling of azoles and thiophenes. Tetrahedron 2012;68:3585-90
   Google Scholar
• Dai C, Xu ZQ, Huang F, et al. Lewis acid-catalyzed, copper(II)-mediated synthesis of heteroaryl thioethers under base-free conditions. J Org Chem 2012;77:4414-19
   PubMed Web of Science ®Google Scholar
• Ding ZH, Yoshikai N. Mild and efficient C2-alkenylation of indoles with alkynes catalyzed by a Cobalt complex. Angew Chem Int Ed 2012;51:4698-701
   PubMedGoogle Scholar
• Ryu J, Cho SH, Chang S. A versatile Rhodium(I) catalyst system for the addition of heteroarenes to both alkenes and alkynes by a C-H bond activation. Angew Chem Int Ed 2012;51:3677-81
   PubMedGoogle Scholar
• Sahnoun S, Messaoudi S, Brion JD, Alami M. Pd/Cu-catalyzed direct alkenylation of azole heterocycles with alkenyl halides. Eur J Org Chem 2010;6097-102
   Google Scholar
• Liu B, Wang Z, Wu NJ, et al. Discovery of a full-color-tunable fluorescent core framework through direct C-H (hetero)arylation of N-heterocycles. Chem Eur J 2012;18:1599-603
   PubMedGoogle Scholar
• Yadav S, Kumar P, Clercq ED, et al. 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation. Eur J Med Chem 2010;45:5985-97
   PubMed Web of Science ®Google Scholar
• Yang Q, Chang J, Wu Q, Zhang BX. A simple phenylation of heteroaromatic compounds using diphenyliodonium triflate. Res Chem Intermed 2012;38:1335-40
   Google Scholar
• Liu B, Guo Q, Cheng YY, et al. Palladium-catalyzed desulfitative C-H arylation of heteroarenes with sodium sulfinates. Chem Eur J 2011;17:13415-19
   PubMed Web of Science ®Google Scholar
• Zhang C, Yu SB, Hu XP, et al. New chiral ferrocenyl P,S-ligands for highly diastereo-/enantioselective catalytic [3+2] cycloaddition of azomethine ylides with cyclic and acyclic enones. Org Lett 2010;12:5542-5
   PubMedGoogle Scholar
• Xin PY, Niu HY, Qu GR, et al. Nickel catalyzed alkylation of N-aromatic heterocycles with Grignard reagents through direct C-H bond functionalization. Chem Commun 2012;48:6717-19
   PubMed Web of Science ®Google Scholar